
Novel мощный and селективный SIRT2 ингибитор, increasing the acetylation level of eukaryotic translation initiation factor 5A (eIF5A) and reducing клетка viability of human breast cancer cells accompanied with a decrease in c-Myc expression
Novel potent and selective SIRT2 inhibitor, increasing the acetylation level of eukaryotic translation initiation factor 5A (eIF5A) and reducing cell viability of human breast cancer cells accompanied with a decrease in c-Myc expression
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.